Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy

作者: Yvonne Hui-Fang Teng , Wai-Jin Tan , Aye-Aye Thike , Poh-Yian Cheok , Gary Man-Kit Tse

DOI: 10.1186/BCR2857

关键词:

摘要: … mutations, notably exon 19 deletions and exon 21 missense (L858R) mutations, in 11.8% of triple negative breast cancers evaluated. All samples showed heterozygous deletions, …

参考文章(46)
John D. Minna, Adi Gazdar, Joyce E. Ohm, Denise Juroske, Jonathan R. Pollack, Michael Peyton, Kiyoshi Yanagisawa, Yuhui Huang, Joseph Amann, J. Stuart Salmon, Hisayuki Shigematsu, David P. Carbone, Pierre P. Massion, Shailaja Kalyankrishna, Young H. Kim, Jonathan M. Kurie, Luc Girard, Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer Cancer Research. ,vol. 65, pp. 226- 235 ,(2005)
Gloria J. Morris, Sashi Naidu, Allan K. Topham, Fran Guiles, Yihuan Xu, Peter McCue, Gordon F. Schwartz, Pauline K. Park, Anne L. Rosenberg, Kristin Brill, Edith P. Mitchell, Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer. ,vol. 110, pp. 876- 884 ,(2007) , 10.1002/CNCR.22836
Dezheng Huo, Francis Ikpatt, Andrey Khramtsov, Jean-Marie Dangou, Rita Nanda, James Dignam, Bifeng Zhang, Tatyana Grushko, Chunling Zhang, Olayiwola Oluwasola, David Malaka, Sani Malami, Abayomi Odetunde, Adewumi O. Adeoye, Festus Iyare, Adeyinka Falusi, Charles M. Perou, Olufunmilayo I. Olopade, Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer Journal of Clinical Oncology. ,vol. 27, pp. 4515- 4521 ,(2009) , 10.1200/JCO.2008.19.6873
Maura N. Dickler, Melody A. Cobleigh, Kathy D. Miller, Pamela M. Klein, Eric P. Winer, Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer Breast Cancer Research and Treatment. ,vol. 115, pp. 115- 121 ,(2009) , 10.1007/S10549-008-0055-9
Wen-Jin Yin, Jin-Song Lu, Gen-Hong Di, Yan-Ping Lin, Li-Heng Zhou, Guang-Yu Liu, Jiong Wu, Kun-Wei Shen, Qi-Xia Han, Zhen-Zhou Shen, Zhi-Ming Shao, Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients Breast Cancer Research and Treatment. ,vol. 115, pp. 325- 333 ,(2009) , 10.1007/S10549-008-0096-0
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
S Banerjee, Basal-like breast carcinomas: clinical outcome and response to chemotherapy Journal of Clinical Pathology. ,vol. 59, pp. 729- 735 ,(2006) , 10.1136/JCP.2005.033043
Tatsuya Toyama, Hiroko Yamashita, Naoto Kondo, Katsuhiro Okuda, Satoru Takahashi, Hidefumi Sasaki, Hiroshi Sugiura, Hirotaka Iwase, Yoshitaka Fujii, Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers BMC Cancer. ,vol. 8, pp. 309- 309 ,(2008) , 10.1186/1471-2407-8-309
Aye Aye Thike, Poh Yian Cheok, Ana Richelia Jara-Lazaro, Benita Tan, Patrick Tan, Puay Hoon Tan, Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer Modern Pathology. ,vol. 23, pp. 123- 133 ,(2010) , 10.1038/MODPATHOL.2009.145